VoxCell BioInnovation

VoxCell BioInnovation’s CEO, Dr. Karolina Valente, will be taking the stage at the Rising Economy Conference 2025 as part of the Rapid-Fire Innovation Showcase! 🎤 📆 Date: March 4, 2025 ⏰ Time: 9:40 AM – 10:10 AM PST 📍 Location: Delta Ocean Pointe Resort (Main Ballroom) In this dynamic session, Dr. Valente will have just 5 minutes and 10 slides to spotlight VoxCell’s groundbreaking work in 3D bioprinting for cancer drug development. With an audience of 230 business leaders, innovators, and changemakers, it’s an incredible opportunity to showcase how we’re revolutionizing the future of drug discovery. If you're attending, be sure to catch this high-energy session moderated by Humaira Ahmed (BestHuman) and featuring fellow innovators from BC Cancer Research Institute and Future Marine. Stay tuned for updates—this is one you won’t want to miss! #RisingEconomy2025 #Innovation #Biotech #3DBioprinting #VoxCellBio #FutureOfMedicine

Celebrating a Changemaker! 🎉 We’re thrilled to share that Dr. Karolina Valente, CEO of VoxCell BioInnovation, has been recognized in The Globe and Mail’s Report on Business 2025 Changemakers Awards! 🏆 This award honors proactive, action-oriented leaders who are driving real change in their industries, and Dr. Karolina Valente is the embodiment of that spirit. Under her leadership, VoxCell BioInnovation is revolutionizing 3D bioprinting with cutting-edge vascularized tissue models—pushing the boundaries of drug discovery and preclinical research. Dr. Karolina Valente’s vision, innovation, and dedication to impact-driven science have not only shaped our company’s success but are also transforming the future of biotech. We are incredibly proud to see her recognized among Canada’s top business leaders! Check out the full list of #ROBChangemakers here: https://lnkd.in/gqKEwSta Congratulations, Dr. Karolina Valente! 🚀 #Leadership #Innovation #Biotech #Entrepreneurship #VoxCellBio #ROBChangemakers

Tomorrow, our CEO, Dr. Karolina Valente will be speaking at the 6th Western Angel Investment Summit in Victoria! She'll be part of the "BC and Canada on the World Stage" panel at 3:30 PM PST, discussing how B.C.'s tech ecosystem can take bold steps toward global competitiveness. With expertise in deep tech and bioprinting, Dr. Karolina Valente will share insights on innovation, investment, and scaling transformative technologies. This event is presented by Angel Forum ™ Vancouver with the support of VIATEC, BDC, and NACO Canada, bringing together founders and investors to explore how #BCBeBold can redefine the future of tech. 🎤 Panelists: 💡 Dr. Karolina Valente - VoxCell BioInnovation 💡 Melaniia Volkodav - Panache Ventures 💡 Peter Cowan - Innovate BC Moderated by Claudio Rojas - CEO, NACO Canada Looking forward to an inspiring discussion on how B.C. can break new ground in the global tech landscape! #WesternAngelSummit #VoxCellBio #TechInnovation #Bioprinting #CanadianTech

✨ VoxCell BioInnovation | January Milestone ✨ Big news! This month, we shipped our first acellular vascularized tissue models to external partners—a major step in advancing 3D culture applications. These ready-to-use, vascularized models empower researchers to enhance their studies and accelerate discoveries in disease modeling and drug development. 🔬 Why it matters: Traditional 3D culture methods have limitations. Our vascularized tissue models provide a more physiologically relevant alternative, offering customizable vascular features, improved reproducibility, and more predictive 3D models for research and preclinical applications. Curious how this could elevate your research? Learn more and connect with us: https://hubs.li/Q036gwzM0 February is shaping up to be just as exciting—stay tuned for more updates! #Bioprinting #TissueEngineering #3DCellCulture #DrugDiscovery #VoxCellBio

Congratulations to BIOTECanada member, VoxCell BioInnovation on reaching the $1M Rocket Fuel Pitch Finals at LEAP 2025! Your work in 3D vascularized tissue models is a testament to Canada’s leadership in biotech innovation and its impact on the future of preclinical cancer drug development. Wishing Dr. Karolina Valente the best as she takes the stage to showcase VoxCell’s groundbreaking technology. Cheering you on from afar! 👏

WE WON! 🚀 VoxCell BioInnovation is honored to receive the LEAP Landing Award—recognizing us as a high-growth non-Saudi startup with the potential to soft-land in KSA! This incredible achievement comes with a $150K USD non-dilutive cash prize, fueling our mission to transform cancer drug development with 3D vascularized tissue models that bring predictive, human-like preclinical research to the forefront. A huge thank you to LEAP 2025, the Rocket Fuel team, and everyone who has supported us on this journey. This is just the beginning—we’re ready to make a global impact! 🔗 Want to collaborate or learn more? Let’s connect! Visit www.voxcellbio.com or reach out to us on LinkedIn! #LEAP2025 #LEAPLandingAward #Biotech #CancerResearch #StartupSuccess #Innovation #VoxCellBioInnovation #FutureOfHealthcare

🌟 3D Bioprinting Focus Poll: What’s Your Expertise? 🌟 At VoxCell BioInnovation, we leverage 3D bioprinting to create advanced vascularized tissue models, driving innovation in drug screening and cancer research. If you're looking for a next-gen solution, check out our Universal Bioinks—designed for 3D bioprinting applications and beyond, offering ease of use and customization for your research needs. 🔽 Vote below and let’s connect! 🔽 #3DBioprinting #Bioprinting #HealthTech #Innovation #Bioinks #RegenerativeMedicine #CancerResearch #TissueEngineering #VoxCellBio

VoxCell BioInnovation is heading to the $1M Rocket Fuel Pitch Finals at LEAP 2025! We’re beyond excited to be among the Top 12 finalists, pushing the boundaries of biotech innovation with our 3D vascularized tissue models—revolutionizing preclinical cancer drug development. A special moment at LEAP: We met with Tim Draper—renowned venture capitalist and founder of Draper Associates, Draper University, and Draper Venture Network. Our journey with Tim started when VoxCell was a finalist on Season 6 of Meet the Drapers—and today, we’re thrilled to have him on our cap table! 🔥 Catch Dr. Karolina Valente LIVE on the Main Stage! 📍 Main Stage, LEAP 2025 ⏰ Tomorrow | 5:40 PM AST She’ll be unveiling how our cutting-edge 3D vascularized tissue models are setting a new standard for predictive, human-like preclinical drug testing. See you at LEAP! 🚀 #LEAP2025 #RocketFuel #Biotech #CancerResearch #MeetTheDrapers #TimDraper #StartupInnovation

Today, on the #InternationalDayofWomenandGirlsinScience, we celebrate the incredible women driving innovation in STEM—especially those shaping the future of biotech. At VoxCell BioInnovation, we are proud to be a women-led company with Dr. Karolina Valente as our Founder & CEO. Our leadership team is 75% women, and 50% of our entire team is made up of brilliant women advancing science, technology, and innovation every day. A special shoutout to the amazing women of VoxCell who are pushing boundaries and making an impact: 🔬 Dr. Karolina Valente 🔬 Genevieve Boice 🔬 Anna Poon 🔬 Asees Kaur 🔬 Annelise Lapointe 🔬 Megan Chisling 🔬 Ekaterina Shteinberg 🔬 Zahra Mantaka Your passion, expertise, and dedication are shaping the future of biotech, and we couldn’t be prouder! To all the women in science—your work is changing the world. Let’s continue breaking barriers together! #WomenInScience #WomenInSTEM #Leadership #Biotech #3DBioprinting #VoxCellBioInnovation

We made it to the finals! 🚀 Out of 2,000 companies that applied, 120 advanced to the semi-finals—now, VoxCell BioInnovation is among the top 12 heading to the $1M Rocket Fuel Pitch Finals at LEAP 2025! 🔥 Catch Dr. Karolina Valente LIVE on the Main Stage! 📍 Main Stage, LEAP 2025 ⏰ Tomorrow | 5:40 PM AST She’ll be showcasing how our 3D vascularized tissue models are transforming cancer drug development, bringing predictive human-like tissues to preclinical research. This is a huge moment for us, and we’re thrilled to share it with you. Follow us for updates after tomorrow! #LEAP2025 #HealthTech #Bioprinting #DeepTech #Innovation #Startups #CancerResearch #VoxCellBio